The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

Share Price Information for Amati Aim Vct (AMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.176%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 85.50
AMAT Live PriceLast checked at -
Amati AIM VCT is an Investment Trust

To generate tax free capital gains and regular dividend income, invests primarily in AIM-traded companies and non-qualifying investments as allowed by the VCT legislation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a supplementary Prospectus

18 Jan 2022 13:47

RNS Number : 8536Y
Amati AIM VCT PLC
18 January 2022
 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

 

18 January 2022

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Publication of a supplementary Prospectus

Amati AIM VCT plc (the "Company") has today published a supplementary prospectus approved by the Financial Conduct Authority (the "Supplementary Prospectus"). The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules following the publication of the Company's interim report and unaudited financial statements for the period ended 31 July 2021.

The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 28 July 2021 in respect of an offer for subscription to raise up to £40 million, together with an over-allotment facility to raise up to a further £25 million.

A copy of the Supplementary Prospectus will shortly be available for inspection at the National Storage Mechanism which is located at https://data.fca.org.uk/#/nsm/mationalstoragemechanism.

The Supplementary Prospectus is also available in electronic form on the Company's website at www.amatiglobal.com.

 

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

 

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Amati AIM VCT plc (the "Company") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Company's securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 28 July 2021 by the Company in connection with the offer for subscription and the supplementary prospectus published on 18 January 2022 related thereto. Copies of the Prospectus and the supplementary prospectus are available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (www.amatiglobal.com). Approval of the Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus. Potential investors are recommended to read the Prospectus and the supplementary prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Company's securities.

The distribution of this Announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This Announcement does not constitute, and may not be construed as, an offer to sell, or the solicitation of an offer to acquire or subscribe for, securities of the Company in any jurisdiction where such offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on the Company or Dickson Minto W.S. The offer and sale of securities of the Company has not been and will not be registered under the applicable securities laws of Australia, Canada, Japan, the Republic of South Africa or the United States. Subject to certain exemptions, the securities of the Company may not be offered to or sold within Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA or to any national, resident or citizen of Australia, Canada, Japan, the Republic of South Africa, the United States, or any member state of the EEA.

This Announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This Announcement is not an offer of securities for sale into the United States. The securities of the Company have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to any national, resident or citizen of the United States. No public offering of securities is being made in the United States. In addition, the Company has not been and will not be registered under the US Investment Company Act of 1940, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIGPUCCGUPPGWR
Date   Source Headline
2nd May 202410:38 amRNSNet Asset Value(s)
1st May 20243:59 pmRNSTotal Voting Rights
30th Apr 20245:03 pmRNSTransaction in Own Shares
26th Apr 20244:29 pmRNSNet Asset Value(s)
22nd Apr 202411:21 amRNSNet Asset Value(s)
15th Apr 202410:36 amRNSNet Asset Value(s)
12th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20241:04 pmRNSNet Asset Value(s)
3rd Apr 202412:15 pmRNSTransaction in Own Shares
2nd Apr 202411:06 amRNSTotal Voting Rights
25th Mar 20242:26 pmRNSTransaction in Own Shares
25th Mar 202412:39 pmRNSNet Asset Value(s)
18th Mar 20241:55 pmRNSNet Asset Value(s)
15th Mar 20243:00 pmRNSTransaction in Own Shares
14th Mar 20245:11 pmRNSCompliance with Market Abuse Regulation
14th Mar 20247:00 amRNSStrategic Review
11th Mar 202410:12 amRNSNet Asset Value(s)
4th Mar 20249:55 amRNSNet Asset Value(s)
1st Mar 20244:18 pmRNSTotal Voting Rights
29th Feb 20242:27 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSNet Asset Value(s)
19th Feb 202410:21 amRNSNet Asset Value(s)
14th Feb 20244:36 pmRNSTransaction in Own Shares
9th Feb 20244:56 pmRNSNet Asset Value(s)
2nd Feb 20246:03 pmRNSTransaction in Own Shares
2nd Feb 202412:15 pmRNSNet Asset Value(s)
1st Feb 20242:21 pmRNSTotal Voting Rights
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 20245:14 pmRNSTransaction in Own Shares
19th Jan 20245:03 pmRNSNet Asset Value(s)
16th Jan 20244:34 pmRNSTransaction in Own Shares
15th Jan 20244:20 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.